Australia’s health regulators are examining the growing use of AI “scribe” tools in general practice, after the federal health department raised concerns about privacy and safeguards. AI scribe systems record clinical conversations, generate transcripts, and produce summaries for medical records, which regulators say are becoming increasingly common in GP settings. In recent months, multiple reporting outlets describe the regulators’ focus on how the tools are implemented in care environments and whether existing oversight is sufficient.
Key issues highlighted include patient consent and whether patients understand how their data are captured and processed, alongside data security and protections against unauthorized access. Sources also point to concerns about the accuracy and reliability of AI-generated documentation and the potential safety implications if clinical records are incomplete or incorrect. The government review is described as considering what additional controls, standards, or safeguards may be needed for clinical use, particularly given the speed of adoption and the limited transparency often associated with deployment in everyday appointments.
